3rd Quarter - Report

THE DUBERSTEIN GROUP INC. for AMGEN INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures - HR 6, 21st Century Cures Act.

LobbyistCovered position, as disclosed
KENNETH DUBERSTEIN —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th)

Taxation/Internal Revenue Code TAX

Corporate tax reform. Treatment of Puerto Rico in tax reform.

LobbyistCovered position, as disclosed
DANIEL P MEYER —

Contacted: HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent reform - HR 9, Innovation Act; S 1137, PATENT Act; HR 2045, Targeting Rogue and Opaque Letters Act of 2015; S 632, STRONG Patents Act of 2015; HR 1896, Demand Letter Transparency Act of 2015.

LobbyistCovered position, as disclosed
DANIEL P MEYER —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (114th), H.R. 1896 (114th), H.R. 2045 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.